Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Resideo Technologies
REZI
$3.1B
| $2.53M | ﹤0.01% |
106,300
+78,100
| +277% | +$1.96M |
|
2052
IRIDEX
IRIX
$14.9M
| $2.53M | ﹤0.01% |
546,812
-16,348
| -3% | -$80.8K |
|
2053
Century Casinos
CNTY
$36M
| $2.53M | ﹤0.01% |
211,687
+3,738
| +2% | +$42.3K |
|
2054
Cineverse
CNVS
$63.9M
| $2.53M | ﹤0.01% |
155,496
-112,485
| -42% | -$1.9M |
|
2055
Quest Resource Holding
QRHC
$33.7M
| $2.53M | ﹤0.01% |
411,192
-53,500
| -12% | -$352K |
|
2056
Ocular Therapeutix
OCUL
$2.2B
| $2.53M | ﹤0.01% |
510,805
+430,705
| +538% | +$2.39M |
|
2057
Pixelworks
PXLW
$44.4M
| $2.52M | ﹤0.01% |
70,850
+8,846
| +14% | +$351K |
|
2058
Endava
DAVA
$164M
| $2.52M | ﹤0.01% |
18,960
-146,503
| -89% | -$18.5M |
|
2059
ALX Oncology
ALXO
$271M
| $2.52M | ﹤0.01% |
148,800
-19,100
| -11% | -$326K |
|
2060
iShares S&P Small-Cap 600 Value ETF
IJS
$8.45B
| $2.51M | ﹤0.01% |
+24,500
| New | +$2.5M |
|
2061
Vroom Inc
VRM
$56.8M
| $2.51M | ﹤0.01% |
11,784
+10,916
| +1,258% | +$5.18M |
|
2062
Precigen
PGEN
$2.18B
| $2.51M | ﹤0.01% |
1,187,590
+1,114,739
| +1,530% | +$2.71M |
|
|
SCS
2063
DELISTED
Steelcase
SCS
| $2.5M | ﹤0.01% |
209,500
-61,500
| -23% | -$743K |
|
2064
First Trust Enhanced Short Maturity ETF
FTSM
$6.54B
| $2.5M | ﹤0.01% |
41,991
+15,491
| +58% | +$924K |
|
2065
Distribution Solutions Group
DSGR
$1.62B
| $2.5M | ﹤0.01% |
129,600
+12,800
| +11% | +$278K |
|
2066
ANI Pharmaceuticals
ANIP
$1.76B
| $2.49M | ﹤0.01% |
88,602
-9,900
| -10% | -$369K |
|
2067
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
| $2.49M | ﹤0.01% |
+54,340
| New | +$2.52M |
|
2068
Rocket Pharmaceuticals
RCKT
$381M
| $2.48M | ﹤0.01% |
156,500
+4,701
| +3% | +$81.2K |
|
2069
Levi Strauss
LEVI
$8.68B
| $2.48M | ﹤0.01% |
+125,400
| New | +$2.71M |
|
2070
CTS Corp
CTS
$1.81B
| $2.48M | ﹤0.01% |
70,100
+6,500
| +10% | +$227K |
|
2071
Mustang Bio
MBIO
$4.5M
| $2.47M | ﹤0.01% |
3,265
+1,675
| +105% | +$1.38M |
|
|
FRBK
2072
DELISTED
Republic First Bancorp Inc
FRBK
| $2.47M | ﹤0.01% |
479,446
-279,227
| -37% | -$1.34M |
|
2073
Black Hills Corp
BKH
$5.66B
| $2.47M | ﹤0.01% |
32,105
+4,813
| +18% | +$335K |
|
2074
Data I/O
DAIO
$32.4M
| $2.47M | ﹤0.01% |
581,528
-64,715
| -10% | -$302K |
|
|
MAXR
2075
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $2.47M | ﹤0.01% |
62,484
-123,518
| -66% | -$3.78M |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.